Wordt geladen...
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
BACKGROUND: Sensitizing effects of poly-ADP-ribose polymerase inhibitors have been studied in several preclinical models, but a clear understanding of predictive biomarkers is lacking. In this study, in vivo efficacy of veliparib combined with temozolomide (TMZ) was evaluated in a large panel of gli...
Bewaard in:
| Gepubliceerd in: | J Natl Cancer Inst |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862419/ https://ncbi.nlm.nih.gov/pubmed/26615020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv369 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|